# K073571: Tricos T Resorbable Bone Substitute

- Pathway: 510(k) (Abbreviated)
- Applicant: Baxter Healthcare Corporation
- Decided: Apr 8, 2008 after 110 days
- Product code: LYC (Bone Grafting Material, Synthetic)
- Device class: 2
- Regulation: 21 CFR 872.3930
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 4 generations back to K990131 (1999). 19 ancestors in all.
2 later devices descend from it; 2 cite it directly.
0 of 22 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K051722: Tricos T, Baxter Healthcare Corp (2005) Summary page 2.
- K033815: Bio-Oss, Bio-Oss Blocks and Bio-Oss Collagen, Geistlich-Pharma (2004) Summary page 1.

## Most influential descendants
- K081717: Tricos a Resorbable Bone Substitute (2008), 0 descendants of its own
- K081721: Tricos a Resorbable Substitute (2008), 0 descendants of its own

## Indications for use
TricOs T Resorbable Bone Substitute is indicated for use as a bone void filler for voids and gaps that are not intrinsic to the stability of the bony structure. It is indicated for surgically created osseous defects or osseous defects resulting from traumatic injury. TricOs T Resorbable Bone Substitute is intended to fill, augment, or reconstruct bony defects of the oral and maxillofacial region. Following placement in bony voids or gaps, TricOs T Resorbable Bone Substitute is resorbed while providing support for the in-growth of bone during the healing process. TricOs T Resorbable Bone Substitute is a bone void filler without initial mechanical properties, therefore rigid fixation techniques are recommended.

Source page: https://510kreport.com/device/K073571
Methodology: https://510kreport.com/methodology